Indoco Remedies Limited

Indoco Remedies Limited (INDOCO) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

indoco.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-03

Stock price
₹272.56
Market cap
2,498 Cr
Stock P/E
38.4
P/B
2.46
Dividend yield
0.1%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales482 Cr459 Cr450 Cr431 Cr433 Cr411 Cr390 Cr438 Cr485 Cr445 Cr476 Cr468 Cr
Operating expenses (approx.)410 Cr397 Cr401 Cr384 Cr392 Cr399 Cr391 Cr420 Cr442 Cr414 Cr426 Cr426 Cr
EBITDA71 Cr63 Cr49 Cr48 Cr40 Cr12 Cr-0.78 Cr18 Cr43 Cr32 Cr50 Cr41 Cr
OPM %14.8%13.7%10.9%11.1%9.3%2.9%-0.2%4.0%8.9%7.1%10.5%8.8%
Other income4 Cr2 Cr3 Cr1 Cr2 Cr0.85 Cr2 Cr2 Cr0.76 Cr0.98 Cr-0.04 Cr2 Cr
Interest8 Cr10 Cr12 Cr14 Cr18 Cr16 Cr18 Cr26 Cr25 Cr26 Cr46 Cr28 Cr
Depreciation21 Cr24 Cr26 Cr28 Cr29 Cr29 Cr29 Cr30 Cr32 Cr32 Cr32 Cr35 Cr
Profit before tax46 Cr23 Cr33 Cr7 Cr-5 Cr-31 Cr-46 Cr-37 Cr-14 Cr-31 Cr-25 Cr78 Cr
Tax %23.9%31.2%33.2%73.9%-106.8%8.3%9.2%0.8%31.9%5.9%5.3%15.8%
Net profit35 Cr16 Cr22 Cr2 Cr-10 Cr-28 Cr-41 Cr-36 Cr-9 Cr-29 Cr-24 Cr65 Cr
EPS (₹)₹3.82₹1.69₹2.39₹0.20₹-1.09₹-3.08₹-4.48₹-3.94₹-1.00₹-3.20₹-2.57₹7.09

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,107 Cr1,242 Cr1,541 Cr1,669 Cr1,817 Cr1,665 Cr1,845 CrSign in for TTM
Operating expenses (approx.)983 Cr1,017 Cr1,213 Cr1,383 Cr1,573 Cr1,566 Cr1,704 CrSign in for TTM
EBITDA123 Cr224 Cr327 Cr286 Cr244 Cr99 Cr142 CrSign in for TTM
OPM %11.1%18.1%21.2%17.1%13.4%6.0%7.7%Sign in for TTM
Other income2 Cr3 Cr2 Cr2 Cr10 Cr5 Cr3 CrSign in for TTM
Interest26 Cr22 Cr14 Cr25 Cr38 Cr66 Cr122 CrSign in for TTM
Depreciation71 Cr73 Cr79 Cr71 Cr92 Cr114 Cr126 CrSign in for TTM
Profit before tax29 Cr132 Cr237 Cr193 Cr136 Cr-74 Cr-107 CrSign in for TTM
Tax %15.6%29.5%34.6%26.2%28.6%-4.8%7.3%Sign in for TTM
Net profit24 Cr93 Cr155 Cr142 Cr97 Cr-78 Cr-99 CrSign in for TTM
EPS (₹)₹2.62₹10.10₹16.80₹15.44₹10.53₹8.46₹-10.70Sign in for TTM
Dividend payout %——8.9%14.6%21.3%——Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital18 Cr18 Cr18 Cr18 Cr18 Cr18 Cr18 Cr
Reserves661 Cr751 Cr886 Cr1,010 Cr1,091 Cr1,004 Cr921 Cr
Borrowings203 Cr213 Cr244 Cr333 Cr672 Cr994 Cr1,036 Cr
Other liabilities389 Cr333 Cr337 Cr297 Cr362 Cr418 Cr625 Cr
Total liabilities1,272 Cr1,315 Cr1,486 Cr1,658 Cr2,145 Cr2,430 Cr2,593 Cr
Fixed assets (net)542 Cr528 Cr532 Cr612 Cr788 Cr849 Cr970 Cr
CWIP7 Cr25 Cr53 Cr55 Cr103 Cr276 Cr28 Cr
Investments0.02 Cr0.02 Cr0.02 Cr2 Cr9 Cr1 Cr1 Cr
Loans & advances0.39 Cr0.40 Cr0.54 Cr0.69 Cr1 Cr3 Cr5 Cr
Inventories208 Cr238 Cr311 Cr326 Cr353 Cr419 Cr405 Cr
Trade receivables210 Cr234 Cr297 Cr351 Cr406 Cr352 Cr489 Cr
Cash & bank24 Cr9 Cr17 Cr11 Cr15 Cr12 Cr26 Cr
Other assets280 Cr280 Cr276 Cr300 Cr469 Cr516 Cr669 Cr
Total assets1,272 Cr1,315 Cr1,486 Cr1,658 Cr2,145 Cr2,430 Cr2,593 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity——174 Cr179 Cr157 Cr95 Cr192 Cr
Cash from investing——-121 Cr-208 Cr-434 Cr-339 Cr-102 Cr
Cash from financing——-44 Cr23 Cr280 Cr241 Cr-77 Cr
Net cash flow——8 Cr-7 Cr3 Cr-3 Cr14 Cr
Free cash flow (OCF − Capex)——49 Cr-28 Cr-271 Cr-261 Cr45 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %8.1%20.1%27.7%16.0%9.8%-0.4%0.8%
ROE %3.5%0.0%17.1%13.8%8.9%-7.2%-10.2%
Debtor days69697077827796
Inventory days289286287288266385347
Days payable230136123109116191264
Cash conversion cycle129218234255232271179
Debt / equity0.300.280.270.320.610.981.11
Current ratio1.231.531.821.901.561.241.13
Net debt / EBITDA0.000.000.001.132.699.897.12

Compare with peers

Loading peers…